Pfdd

What is Patient-Focused Drug Development (PFDD)?

National Organization for Rare Disorders (NORD)

Lupus PFD Meeting - FDA PFDD Initiative

Lupus Research Alliance

Lupus PFDD Meeting - FDA Insights on PFDD and Lupus

Lupus Research Alliance

Lupus PFDD Meeting - FDA Summary and Closing Remarks

Lupus Research Alliance

Pancreatitis Externally-Led PFDD Meeting – Introduction & Meeting Overview (James Valentine)

National Pancreas Foundation

Pancreatitis Externally-Led PFDD Meeting – FDA Meeting Overview (Erica Lyons, MD)

National Pancreas Foundation

Cure Kinley and Kennedy - GM1 EL-PFDD

Cure GM1 Foundation

FDA Discusses the Importance of PFDD Meetings

Arthritis Foundation

Pancreatitis Externally-Led PFDD Meeting – Acute & Chronic Pancreatitis (Adult Panel)

National Pancreas Foundation

Patient-Focused Drug Development (PFDD) Meeting For Krabbe Disease

National Organization for Rare Disorders (NORD)

FDA's PFDD Initiative - Road to Clinical Trial Endpoints

Lupus Foundation of America

NPC PFDD - Key Points and Closing Remarks

Ara Parseghian Medical Research Fund

EL-PFDD Introductory Webinar

Patient Focused Drug Development (PFDD) #4 - How to Begin the Process in SCI?

Annual SCI Investor Symposium

EL-PFDD Opening and presentations by Dr Lowy & Dr Rubin

HypoPARAthyroidism Association

HypoPARAthyroidism Externally-Led Patient Focused Drug Development Meeting (EL-PFDD)

HypoPARAthyroidism Association

Community Information Session: Learn More About AFTD’s March 5th Externally Led PFDD Meeting

NPC PFDD - FDA's Approach to Rare Disease Drug Development and the Importance of the Patient Voice

Ara Parseghian Medical Research Fund

NPC PFDD - Open Comments - Current approach to treating NPC (Late Infantile and Juvenile)

Ara Parseghian Medical Research Fund